StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by valentinemassonon Jun 10, 2020 11:14am

67 Views

Post# 31133379

RE:RE:RE:RE:RE:RE:RE:RE:Sorry we aren't selling. Nice try

Jonnyboy85 wrote: The 40 million u.s. contract was signed in october, there was a 6 month marketing period to start the contract. That 6 months ended in april which means we would never see a penny until Q2 at the earliest, these bashers know that and they're just picking on ya newbs.

Thanks for the information.

Bullboard Posts

Anaergia expands relationship with PepsiCo